Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10227620 | Biomaterials | 2014 | 9 Pages |
Abstract
Nanocarriers and nanoparticles remain an intense pharmaceutical and medical imaging technology interest. Their entry into clinical use is hampered by the lack of reliable in vitro models that accurately predict in vivo toxicity. This study evaluates a 3-D kidney organoid proximal tubule culture to assess in vitro toxicity of the hydroxylated generation-5 PAMAM dendrimer (G5-OH) compared to previously published preclinical in vivo rodent nephrotoxicity data. 3-D kidney proximal tubule cultures were created using isolated murine proximal tubule fractions suspended in a biomedical grade hyaluronic acid-based hydrogel. Toxicity in these cultures to neutral G5-OH dendrimer nanoparticles and gold nanoparticles in vitro was assessed using clinical biomarker generation. Neutral PAMAM nanoparticle dendrimers elicit in vivo-relevant kidney biomarkers and cell viability in a 3-D kidney organoid culture that closely reflect toxicity markers reported in vivo in rodent nephrotoxicity models exposed to this same nanoparticle.
Related Topics
Physical Sciences and Engineering
Chemical Engineering
Bioengineering
Authors
Anna I. Astashkina, Clint F. Jones, Giridhar Thiagarajan, Kristen Kurtzeborn, Hamid Ghandehari, Benjamin D. Brooks, David W. Grainger,